Stock OCGN OCUGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Ocugen, Inc.

Equities

OCGN

US67577C1053

Real-time Estimate Cboe BZX
Other stock markets
 11:02:32 2024-05-20 am EDT 		5-day change 1st Jan Change
1.915 USD +0.26% Intraday chart for Ocugen, Inc. +6.08% +233.91%
May. 15 Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study MT
May. 15 Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. OCGN Stock
  4. Revisions Ocugen, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW